Latest Regulatory News

360 Capital Mortgage REIT has announced an estimated ordinary dividend of AUD 0.052 per unit for January 2025, alongside its election to adopt the Attribution Managed Investment Trust (AMIT) regime.

ECP Emerging Growth Limited has reported steady financial health and full compliance with its convertible notes obligations for the quarter ended December 2024, maintaining a conservative loan-to-value ratio and an unchanged conversion price.

Altamin Limited has completed the acquisition of Appian Italy’s 29.85% stake in Vedra Metals, gaining 100% ownership of the Gorno Project and positioning itself for streamlined development or sale.

Southern Cross Gold Ltd has officially become a wholly owned subsidiary of Southern Cross Gold Consolidated Ltd following a scheme of arrangement, with shareholders receiving new securities and the company set for ASX delisting.

Arrow Minerals Ltd has temporarily paused trading of its securities, signaling an imminent announcement that could influence its market position.

Infinity Lithium updates on regulatory feedback delaying its San José mining licence and pivots to larger European funding opportunities, signaling a strategic shift in project development.

IDT Australia has finalized a $20 million asset-based loan facility with ScotPac, replacing its previous $4.7 million NAB facility, to support its expanding sales pipeline and recent contract wins.

The Takeovers Panel has declined to investigate Global Lithium Resources Limited's claims of undisclosed shareholder associations ahead of its AGM, citing untimeliness and lack of merit.

Winsome Resources has taken a significant step forward in developing its Adina Lithium Project by submitting the Preliminary Information Statement to Quebec authorities, initiating a structured permitting process and enhancing stakeholder engagement.

Delta Lithium reports promising drilling outcomes at its fully permitted Mt Ida Gold Project, confirming resource growth potential and endorsing a standalone development strategy.

Pengana Private Equity Trust has updated the Dividend Reinvestment Plan (DRP) price for its upcoming ordinary distribution, maintaining a steady payout of AUD 0.03176 per unit for the half-year ending December 2024.

Clarity Pharmaceuticals has secured a second FDA Fast Track Designation for its 64Cu-SAR-bisPSMA diagnostic agent, aiming to revolutionize prostate cancer imaging and speed regulatory approval.